WebCSL’s world-class R&D organization continues to evolve as a biotechnology leader by advancing high-quality science and technology through innovative collaborations between our high-calibre scientists. What stands CSL in good stead is our quantitative approach to understanding the nature and biology of a disease at a molecular and cellular ...
CSL Behring Patents
WebCSL's 2024 Half Year Financial Results - Announcement Information. We have announced our 2024 Half Year Results for the period ending 31st December 2024. Announcement Information and Webcast Recording were released on Tuesday, 14th February 2024 (AEDT). Please click the 'Learn More' link for full information. Learn More. WebCSL Plasma is one of the world's largest collectors of human plasma. Our work helps to ensure that people with rare and serious diseases are able to live normal, healthy lives. We are committed to our work because lives depend on us. Learn more about CSL Plasma. We want CSL to reflect the world around us grand hotel and spa check in time
2012年5月医療業界232: アクテリオン ファーマシューティカルズ
WebSep 26, 2024 - CSL Behring K.K. (Head Office: Minato-ku, Tokyo; President and Representative Director: Jean-Marc Morange) announces that it has received a manufacturing and marketing approval from the Ministry of Health, Labour and Welfare for “Berinert® S.C. Injection 2000,” a lyophilized human C1-esterase inhibitor concentrate... WebFinancial Results and Information CSL Limited WebCSL Plasma is One of the World’s Largest Collectors of Human Plasma As a leader in plasma collection, CSL Plasma is committed to excellence and innovation in everything we do. Our work ensures that tens of thousands of people can live normal, healthy lives. We are committed to our work because lives depend on us. chinese ferndown